Search Results for "Blue Oval Pill With 68 Taro"

00:38 EDT 3rd August 2015 | BioPortfolio

Matching Channels

Blue hues

Von Willebrand's Disease

von Willebrand disease (vWD) is the most common hereditary coagulation abnormality described in humans, although it can also be acquired as a result of other medical conditions. It arises from a qua...

Matching News

Taro to Announce Third Quarter Results on February 10, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2014, after the c...

Taro to Announce First Quarter Results on August 6, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and three months ended June 30, 2015, after the clos...

From blue pill to blue light

(ETH Zurich) Taking men's concerns seriously: ETH biotechnologists are developing a biotech solution for erectile dysfunction that consists of a gene construct and a blue light.

Taro to Announce Results for Year Ended March 31, 2015 on May 26, 2015

Earnings Call to Discuss Results to be Conducted Thursday, May 28 at 8:00 am ET Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to releas...

E-pill Medication Reminders launches kitchen fixture pill dispenser

Michael JohnsenE-pill Medication Reminders on Wednesday launched a pill dispenser that can be mounted under a kitchen cabinet.  read more

How Cigna Deal Limits Anthem's Blue Cross Brand

When health plans operate using the Blue Cross and Blue Shield brand, they are generally limited to business in a specific state or region as part of a licensing agreement with their trade group, the ...

Blue Cross and Blue Shield of Minnesota Names Two Vice Presidents in Government Programs Business

EAGAN, Minn (PRWEB) February 16, 2015 Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced that Cynthia MacDonald has been named vice president and CEO of Blue Cross and Blue Shield...

TARO: Yes, We Have A Winner

Matching PubMed Articles

Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial.

FEM-PrEP did not demonstrate a reduction in HIV acquisition because of low study pill adherence. Yet, plasma and intracellular drug concentrations indicated that some participants had evidence of rece...

Characterization by Small RNA Sequencing of Taro Bacilliform CH Virus (TaBCHV), a Novel Badnavirus.

RNA silencing is an antiviral immunity that regulates gene expression through the production of small RNAs (sRNAs). In this study, deep sequencing of small RNAs was used to identify viruses infecting ...

Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in High fructose-fed rats.

Simiao pill is one of the most frequently prescriptions in traditional Chinese medicine to treat hyperuricemia and gout. This study was to investigate the protective effects of Simiao pill on renal gl...

Role of miR-21 in rat hepatic oval cell proliferation and activation.

To investigate the possible mechanisms of miR-21-mediated regulation of proliferation and activation of hepatic oval cells.

Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis.

The aim of this study was to investigate histomorphological and immunophenotypic features in pill-induced esophagitis. We comparatively evaluated the histomorphological, immunophenotypic features of p...

Search Whole site using Google


Advertisement Advertisement